Stay updated on Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T20:39:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2 in the study documents section; this is a metadata update that does not alter participant criteria, endpoints, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:40:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 in the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:30:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Introduces a new 'Show glossary' option and includes minor label/copy tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), plus a footer update to 'Revision: v3.4.0' replacing the previous version.
    Difference
    0.1%
    Check dated 2026-01-28T19:50:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4; the previous Revision: v3.3.3 is no longer displayed.
    Difference
    0.0%
    Check dated 2026-01-14T03:47:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section with state listings (Arizona, California, Hawaii, Indiana, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Washington) and updated the revision to v3.3.3. Some state location subsections were removed, and the HHS Vulnerability Disclosure notice was also removed.
    Difference
    0.8%
    Check dated 2025-12-23T20:39:05.000Z thumbnail image

Stay in the know with updates to Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.